Hyperhidrosis Archives - MPR

Hyperhidrosis

Novel Treatment for Primary Axillary Hyperhidrosis Gets FDA Approval

The approval was supported by Phase 3 data from the ATMOS-1 and ATMOS-2 trials which evaluated the absolute change from baseline in sweat production after treatment with Qbrexza, and the proportion of patients who achieved ≥4-point improvement from baseline in their sweating severity (as measured by the Axillary Sweating Daily Diary [ASDD]).